Description
VS-5584 inhibits PI3K and displays anticancer chemotherapeutic activity, inhibiting cell proliferation in a variety of cancer cell lines and suppressing tumor growth in animal models of gastric cancer.
Product Unit Size | Cost | Quantity | Stock |
---|
VS-5584 inhibits PI3K and displays anticancer chemotherapeutic activity, inhibiting cell proliferation in a variety of cancer cell lines and suppressing tumor growth in animal models of gastric cancer.
Cas No. | 1246560-33-7 |
---|---|
Purity | ≥98% |
Formula | C17H22N8O |
Formula Wt. | 354.41 |
IUPAC Name | 5-(8-methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine |
Synonym | SB2343, SB-2343, VS5584 |
Solubility | DMSO 71 mg/mL (200.33 mM) Ethanol 3 mg/mL (8.46 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Hart S, Novotny-Diermayr V, Goh KC, et al. VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer. Mol Cancer Ther. 2013 Feb;12(2):151-61. PMID: 23270925.
ACE inhibitor.
TRPV4 agonist
Triazole; 14-α demethylase and aromatase inhib...
Voltage-gated Na+ channel blocker, mAChR antago...
Selective inhibitor of LRRK2.
PLK1 inhibitor.
EGFR inhibitor.
Dipeptide; aminopeptidase (N/CD13) inhibitor.
Dihydropyridine; L-type Ca2+ channel blocker.
Peptide, c-Kit ligand fragment.
Nicotinamide analog prodrug; fatty acid synthet...
MEK1/2 and Raf inhibitor.
Endogenous glycoprotein; lactoferrin agonist.
Diterpene found in brewed, unfiltered coffee; F...
Mycotoxin produced by Fusarium fungi that infec...
Endogenous peptide hormone; guanyl cyclase C ag...
Azapirone; α1-adrenergic and 5-HT1A partial ag...
β1-adrenergic antagonist.
MurA and isopentenyl mevalonate kinase inhibito...
FAK inhibitor.